S Matthaei1. Show Affiliations » 1. Diabetes-Zentrum Quakenbrück, Fachabteilung für Diabetologie, Endokrinologie & Stoffwechselerkrankungen am Christlichen Krankenhaus Quakenbrück.
Abstract
Entities: Chemical Disease
Mesh： See more » Blood Glucose/metabolismBlood Pressure/drug effectsBody Weight/drug effectsCanagliflozinClinical Trials, Phase III as TopicDiabetes Mellitus, Type 2/bloodDiabetes Mellitus, Type 2/drug therapyGlucosides/adverse effectsGlucosides/therapeutic useGlycated Hemoglobin A/metabolismHumansHypoglycemic Agents/administration & dosageHypoglycemic Agents/therapeutic useRandomized Controlled Trials as TopicSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsThiophenes/adverse effectsThiophenes/therapeutic use
Substances： See more » Blood GlucoseGlucosidesGlycated Hemoglobin AHypoglycemic AgentsSLC5A2 protein, humanSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsThiopheneshemoglobin A1c protein, humanCanagliflozin
Year: 2014 PMID： 24481634 DOI： 10.1055/s-0033-1359992
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN： 0012-0472 Impact factor: 0.628